Skip to content

5-MeO-DMT: all studies

Page 99 of 110: studies 981 to 990 of 1,096, newest first. Back to the 5-MeO-DMT overview

Research

Indoleamine and the phenethylamine hallucinogens: mechanisms of psychotomimetic action

Drug and Alcohol Dependence June 1, 1998 Gerard J. Marek, George K. Aghajanian 39 citations

The psychedelic hallucinogens are comprised of three different groups of compounds according to Ž . Ž . their chemical structure Fig. 1 : 1 the ergolines Ž which contain an indole moiety e.g. lysergic acid . Ž . diethylamide, LSD ; 2 simple indoleamine hallucinoŽ gens e.g. N,N-dimethyltryptamine, DMT and psilocy. bin which share an indoleamine structure with the Ž endogenous neurotransmitter...

Effects of Ayahuasca on the human EEG

Phytomedicine April 1, 1998 Neville S. Arachchige Don, Bruce E. Mcdonough, Gabriel Acácio de Moura et al. 33 citations

EEG data were recorded under field conditions from 11 members of the Santo Daime Doctrine, a Brazilian shamanistic religion, before and after ingesting the psychoactive alkaloid preparation, ayahuasca, or daime, as they term it. Post-ingestion, we observed increases in power in the 36-44 Hz frequency band ("40 Hz") from the left occipital-temporal-parietal scalp electrodes in the eyes-closed...

Psychedelic Effects of Ketamine in Healthy Volunteers

Anesthesiology 1998 Andrew t. Bowdle, Allen d. Radant, Deborah s. Cowley et al. 371 citations

Background Ketamine has been associated with a unique spectrum of subjective "psychedelic" effects in patients emerging from anesthesia. This study quantified these effects of ketamine and related them to steady-state plasma concentrations. Methods Ketamine or saline was administered in a single-blinded crossover protocol to 10 psychiatrically healthy volunteers using computer-assisted...

DOI: 10.1097/00000542-199801000-00015 (opens in new tab) Ketamine ketamine levels Ketamine concentrations Potent psychedelic compounds Dose-response relationship direct +9

Altered consciousness states and endogenous psychoses: a common molecular pathway?

Schizophrenia Research December 19, 1997 Jorge Ciprian-Ollivier, M G Cetkovich-Bakmas 34 citations

Interest in the role of indolamines in the pathogenesis of psychoses has been renewed in recent years by the development of atypical antipsychotic drugs such as clozapine, olanzapine, and risperidone, which act on serotonin receptors. Discovery of the hallucinogenic compounds called methylated indolealkyalamines (MIAs) (e.g. N,N-dimethylserotonin, or bufotenin, and N,N-dimethyltryptamine, or...

Synthesis of 131I derivatives of indolealkylamines for brain mapping

Journal of Labelled Compounds and Radiopharmaceuticals August 1, 1997 Jose A. Sintas, Arturo Alberto Vitale 12 citations

The synthesis and spectral properties of new radioiodinated indolealkylamines like 2-[131I]-iodo-N,N-dimethyltryptamine, 2-[131I]-iodo-N-methyltryptamine, 2-[131I]-iodo-5-methoxy-N,N-dimethyltryptamine, 2-[131I]-iodio-5-hydroxy-N,N-dimethyltryptamine (2-[131I]-iodo-bufotenine), and 2-[131I]-iodo-tryptamine and the known 2-[131I]-iodo-N-acetly-5-methoxy-tryptamine (2-[131I]-iodo-melatonine) are...

alpha2-Adrenoceptor antagonists reverse the 5-HT2 receptor antagonist suppression of head-twitch behavior in mice.

Pharmacology, Biochemistry, and Behavior March 1997 Kinzo Matsumoto, Maho Mizowaki, S Thongpraditchote et al.

The alpha2-adrenoceptor agonist clonidine, as well as 5-HT2 receptor antagonists, reportedly suppress 5-HT2 receptor-mediated head-twitch behavior. We investigated the effect of alpha2-adrenoceptor antagonists on the suppressive action of 5-HT2 receptor antagonists in mice pretreated with the noradrenaline toxin 6-hydroxydopamine (6-OHDA) or the 5-HT synthesis inhibitor p-chlorophenylalanine...

Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs.

Journal of Neurochemistry December 1, 1996 R A Newton, S L Phipps, T P Flanigan et al. 46 citations

Stable transfection of the human neuroblastoma cell line SH-SY5Y with the human 5-hydroxytryptamine2A (5-HT2A) or 5-HT2C receptor cDNA produced cell lines demonstrating ligand affinities that correlated closely with those for the corresponding endogenous receptors in human frontal cortex and choroid plexus, respectively. Stimulation of the recombinant receptors by 5-HT induced phosphoinositide...

Role of hippocampal 5-HT1A receptors on elevated plus maze exploration after a single restraint experience.

Behavioural Brain Research May 1, 1996 S M Netto, Francisco S Guimarães 45 citations

Previous studies have shown that 2 h restraint stress induces deficits in open arm exploration of an elevated plus maze 24 h later. This effect was attenuated by a post-stress systemic injection of the 5-HT non-selective agonist, 5-methoxy-N,N-dimethyltryptamine (5-MeODMT). To verify a possible involvement of hippocampal 5-HT1A receptors in this effect, rats were stereotaxically implanted with...

The Use of Hallucinogens in the Treatment of Addiction

Addiction Research & Theory 1996 John H. Halpern 63 citations

AbstractResearch into treating drug dependence with hallucinogens, although promising, ended with questions still unanswered because of varying, in some cases skeptical, methodology and insufficient adherence to a double-blind, placebo-controlled design. Interest is again emerging, especially with the recent patenting in the United States of ibogaine for its apparent anti-craving properties. A...

Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists.

European Journal of Pharmacology November 3, 1994 Gary A. Gudelsky, Bryan K. Yamamoto, J F Nash 144 citations

The effects of the 5-HT2 receptor agonists 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and 5-methoxy-N,N-dimethyltryptamine (5-MeODMT) on 3,4-methylenedioxymethamphetamine (MDMA)-induced dopamine release and 5-HT depletion in the striatum were studied. The MDMA-induced increase in the extracellular concentration of dopamine in the striatum was enhanced significantly in rats treated with...